Altimmune, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Altimmune, Inc. will hold its 2026 Annual Meeting to vote on director elections, auditor ratification, executive pay, and proposals to increase authorized common stock and expand its employee stock purchase plan.
NASDAQ
Altimmune, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on September 25, 2025, focusing on director elections, auditor ratification, and executive compensation.
NASDAQ
Altimmune, Inc. has scheduled its 2024 Annual Meeting of Stockholders for September 26, 2024, to be held virtually, where stockholders will vote on director elections, auditor ratification, executive compensation, and other business matters.